Biodesix Inc
BDSX
$27.96-3.79%
End of day · as of Oct 7, 2026, 7:15 AM ET
Mkt cap
$157.62M
EV/Sales
2.13
P/E ratio
N/A
FY2025 Revenue
$88.50M
EPS (TTM)
$-6.03
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-39.85%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Biodesix Inc (BDSX) is a diagnostics & research company listed on NASDAQ.
Latest reported BDSX revenue for 2025-12-31 was $88.5M. Net income was -$35.3M. Revenue was up 24.1% from 2024-12-31 to 2025-12-31. BDSX currently screens at market cap $157.6M.
Use this BDSX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full BDSX income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Biodesix Inc (BDSX) is a diagnostics & research company in the Healthcare sector.
Latest cached Biodesix Inc (BDSX) revenue for Dec 31, 2025 was $88.5M. Net income was -$35.3M. Statements: https://lician.com/financials/bdsx
Biodesix Inc (BDSX) market capitalization is $157.6M on the latest cached snapshot.
Biodesix Inc (BDSX) cached previous close $29.06; day range $27.52 – $29.99; volume 102,135. Session quote: https://lician.com/quote/bdsx
Biodesix Inc (BDSX) latest cached earnings event is "BDSX earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached BDSX filing is 8-K/A · Jan 12, 2026. Filings: https://lician.com/sec/bdsx